Does VEDOLIZUMAB Cause Neoplasm? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Neoplasm have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.1% of all adverse event reports for VEDOLIZUMAB.
36
Reports of Neoplasm with VEDOLIZUMAB
0.1%
of all VEDOLIZUMAB reports
2
Deaths
13
Hospitalizations
How Dangerous Is Neoplasm From VEDOLIZUMAB?
Of the 36 reports, 2 (5.6%) resulted in death, 13 (36.1%) required hospitalization.
Is Neoplasm Listed in the Official Label?
Yes, Neoplasm is listed as a known adverse reaction in the official FDA drug label for VEDOLIZUMAB.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Neoplasm?
ADALIMUMAB (513)
OCTREOTIDE (366)
RITUXIMAB (323)
LENALIDOMIDE (242)
CYCLOPHOSPHAMIDE (221)
BEVACIZUMAB (207)
INFLIXIMAB (201)
ETANERCEPT (194)
RIBOCICLIB (194)
METHOTREXATE (165)
Which VEDOLIZUMAB Alternatives Have Lower Neoplasm Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB